Problem Is the problem a priority? | ||
Judgment | Research evidence | Additional considerations |
Probably yes | In epidemiological studies, there is a relationship between the amount of aerobic exercise (at least 150 min/week) and health outcomes20. The identification of a minimum useful threshold of the duration of physical exercise needed for a therapeutic effect in type 2 diabetes is clinically relevant | |
Desirable Effects How substantial are the desirable anticipated effects? | ||
Judgment | Research evidence | Additional considerations |
Small | After updating the previous meta-analysis19 a significant lower fat mass (%) was observed among patients allocated to the intervention group. No differences in HbA1c, BMI | |
Undesirable Effects How substantial are the undesirable anticipated effects? | ||
Judgment | Research evidence | Additional considerations |
Trivial | No relevant risk associated with physical exercise duration was detected in available RCTs, even after updating the previous meta-analysis30 | |
Certainty of evidence What is the overall certainty of the evidence of effects? | ||
Judgment | Research evidence | Additional considerations |
Very low | Very low for all critical outcomes | |
Values Is there important uncertainty about or variability in how much people value the main outcomes? | ||
Judgment | Research evidence | Additional considerations |
No important uncertainty or variability |
No evidence of variability or uncertainty HbA1c and BMI are already considered among critical outcomes of the treatment of type 2 diabetes by scientific societies |
|
Balance of effects Does the balance between desirable and undesirable effects favor the intervention or the comparison? | ||
Judgment | Research evidence | Additional considerations |
Probably favors the intervention | Small but significant effect on HbA1c | |
Resources required How large are the resource requirements (costs)? | ||
Judgment | Research evidence | Additional considerations |
Trivial | No specific evidence is available on this issue | |
Certainty of evidence of required resources What is the certainty of the evidence of resource requirements (costs)? | ||
Judgment | Research evidence | Additional considerations |
Very low | No specific evidence is available on this issue | |
Cost-effectiveness Does the cost-effectiveness of the intervention favor the intervention or the comparison? | ||
Judgment | Research evidence | Additional considerations |
Probably favors the intervention | Small advantage for HbA1c at no estimated additional cost | |
Equity What would be the impact on health equity? | ||
Judgment | Research evidence | Additional considerations |
Probably no impact | No expected differences in costs and accessibility | |
Acceptability Is the intervention acceptable to key stakeholders? | ||
Judgment | Research evidence | Additional considerations |
Probably yes | No specific evidence is available on this issue | |
Feasibility Is the intervention feasible to implement? | ||
Judgment | Research evidence | Additional considerations |
Yes | No additional costs or resources are required |